To include your compound in the COVID-19 Resource Center, submit it here.
The open-label, U.S. Phase IV CLUE trial in 226 patients admitted to the emergency room with 2
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury